A personalized approach to cancer treatment: how biomarkers can help.
about
Biomarker discovery and development in pediatric critical care medicine.Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.Molecular imaging in therapeutic efficacy assessment of targeted therapy for nonsmall cell lung cancerHypoglycemia, an atypical early sign of hepatocellular carcinoma.Salivary analysis of oral cancer biomarkers.Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onsetProtein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4.HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escapeA review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.A Magneto-Nanosensor Immunoassay for Sensitive Detection of Aspergillus Fumigatus Allergen Asp f 1.Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.Preliminary Study on Serum Lactate Dehydrogenase (LDH)-Prognostic Biomarker in Carcinoma Breast.Future Prospects in Breast Cancer Research - Cancer Stem Cells.A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.Advances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer.Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.Identifying predictive markers for personalized treatment selection.Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.Preoperative serum tissue polypeptide-specific antigen is a valuable prognostic marker in breast cancer.Analytical pitfalls and challenges in clinical metabolomics.The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?Plasma surface modification of electrospun fibers for adhesion-based cancer cell sorting.RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.BreCAN-DB: a repository cum browser of personalized DNA breakpoint profiles of cancer genomes.DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.Personalised treatment for cancer: role of biomarkers.Predictors of adherence to exercise interventions during and after cancer treatment: a systematic review.Inter-Alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.CONCORD biomarker prediction for novel drug introduction to different cancer types.Versatile immunoassays based on isomagnetophoresis.Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.
P2860
Q30428168-1CAAF5A6-7D03-4452-A48B-B3E2A80BC4DFQ33714886-F7493752-6BB5-4A02-B26A-9544F6DBB65AQ34145916-C16FFBCD-D8C7-4DA6-9F53-C05FABB781A8Q34243500-496D0E53-A5C0-4F8B-8943-2F89F2B93A67Q34617432-21714E60-DD97-43E3-9DDC-10E18381FA2BQ35005649-DB249848-A14B-4B3A-BBE5-A9EAC0BD0EBBQ35143420-A7A7020D-2025-4E9A-804B-EE121AE352E6Q35165247-0E6120FC-9E64-47B9-AFCC-6119991D4443Q35176173-4A7090BE-5EDC-4702-9107-D34BB4437C3AQ35584153-337C79EB-B593-41F7-B711-40CFAC87FCBEQ35677914-C4A49F09-7C1E-472C-89C2-5EE277D0BE99Q36299382-7DD8780E-C310-4503-A408-25540EAADEE0Q36675207-44E4AB26-50DA-46F7-A8F3-DFD39A9FF06AQ36792659-BD4A3450-3583-4FE2-BEA1-E9B767AB2393Q36830962-8C24C302-F0C7-4DDE-B697-190E53579822Q37155217-65269201-7920-4AFA-A0BC-634FD4F87FCEQ37206443-7310424D-829C-43C1-A29D-5E121F253436Q37344219-7D3B8E71-CB2D-4FF4-A990-AF52F723BA30Q37605872-BE3C9B5E-5555-450C-BCCC-05852A7B7C80Q37702844-09B96B46-1E5F-483C-B80E-382B6F0A6DA8Q37809871-1F9BBC24-CD44-4794-A94C-61542BE09289Q37990022-9C2FA8CF-C11F-4D3E-B46C-545A1FC53FB5Q38460431-99CE7C6A-BA18-419C-BC99-2CB407C903F7Q38870813-17EB8065-1195-4743-878F-CE8C6C404EB5Q39150032-9FF714CA-3CB3-41B3-B50B-149C41253929Q39308196-5EF5A4A8-EAEE-44B3-A426-87C3A86CCFE6Q39325857-78A53B9D-CA31-42AE-83F0-6E82725433C6Q39456396-6FF5099C-6BF5-458B-ABDC-858ABB772480Q40299270-542832E4-6AAA-403D-8539-6EACCA38D6B2Q41638376-2BCAC823-8DFE-4602-8BD1-7DB78AA294AAQ41725997-6F4B422B-1EA0-4526-B880-0F242BF86E23Q46040743-E1C90C34-A808-4C4A-B3C4-B84DD98B66FEQ47301134-EA8F2C26-7EE9-426F-A4A2-592321711FAEQ48188925-6FF50F53-75FB-4053-A64C-7B09AF297FE4Q50128212-1E81468F-F2A5-4596-A048-F92A2143197AQ51548952-63CC6BE3-C98D-4911-A804-0262535F3572Q55309345-7C38E826-BFCB-4DEF-BBEA-3E6D6DFB4550
P2860
A personalized approach to cancer treatment: how biomarkers can help.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A personalized approach to cancer treatment: how biomarkers can help.
@ast
A personalized approach to cancer treatment: how biomarkers can help.
@en
A personalized approach to cancer treatment: how biomarkers can help.
@nl
type
label
A personalized approach to cancer treatment: how biomarkers can help.
@ast
A personalized approach to cancer treatment: how biomarkers can help.
@en
A personalized approach to cancer treatment: how biomarkers can help.
@nl
prefLabel
A personalized approach to cancer treatment: how biomarkers can help.
@ast
A personalized approach to cancer treatment: how biomarkers can help.
@en
A personalized approach to cancer treatment: how biomarkers can help.
@nl
P1433
P1476
A personalized approach to cancer treatment: how biomarkers can help.
@en
P2093
John Crown
Michael J Duffy
P304
P356
10.1373/CLINCHEM.2008.110056
P407
P577
2008-09-18T00:00:00Z